ArticleMedComm2024

Targeting polymorphonuclear myeloid-derived suppressor cells in the immunosuppressive tumor microenvironment for cancer immunotherapy.

Shiqi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.